Brazilian health authorities said this weekend that the State of São Paulo had recorded over 500 cases of monkeypox, most of them in the City of São Paulo (442 of the total 538). The first infection was registered in the state on June 9.
As a result of the Covid-19 pandemic, governments across the world are turning their eyes to the importance of having a strong national life sciences industry – one that is capable of conducting fast, quality research and develop new health technologies to tackle incoming global health security threats.
The Butantan Institute in Sao Paulo has reportedly developed a vaccine of its own against covid-19 and is awaiting clearance from the National Health Surveillance Agency (Anvisa) to start clinical trials in humans.
The Director of the Butantan Institute on Tuesday contradicted the words of Uruguayan President Luis Lacalle Pou, assuring that there is not yet a closed agreement between the Uruguayan government and the Chinese laboratory Sinovac for the purchase of the vaccine against Covid-19. However, the institute affirmed that there is a pre-agreement and talks are still ongoing. Lacalle Pou announced on Saturday at a press conference the purchase of 1.75 million doses from this laboratory.